Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information

Repertaxin L-lysine salt

EU orphan designation number: EU/3/01/058   
Active ingredient: Repertaxin L-lysine salt
Indication: Prevention of delayed graft function in organ transplant
Sponsor: Dompé farmaceutici S.p.A.
Via Santa Lucia 6, 20122 Milano, Italia

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
21/09/2001 Orphan designation EMEA/OD/012/01 (2001)2715 of 19/09/2001
04/04/2007 Transfer of orphan designation EMEA/OD/012/01/T/01 (2007)1597 of 02/04/2007
18/02/2010 Transfer of orphan designation EMEA/OD/012/01/T/02 (2010)966 of 12/02/2010
23/03/2015 Transfer of orphan designation EMA/OD/012/01/T/03 (2015)2041 of 19/03/2015